(1112) - Safety and Efficacy of Belatacept in Heart Transplant Patients with Chronic Kidney Disease or Intolerance to Calcineurin Inhibitors

Autor: ce:underline>Yehya, A., Ham, P., Pearston, A., Ingemi, A., Cohan, D., Mandel, J., Badiye, A., Herre, J.

Publikováno v: In Journal of Heart and Lung Transplantation April 2024 43(4) Supplement:S517-S517

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women

Autor: Tran, AH, Best, BM, Stek, A, Wang, J, Capparelli, EV, Burchett, SK, Kreitchmann, R, Rungruengthanakit, K, George, K, Cressey, TR, Chakhtoura, N, Smith, E, Shapiro, DE, Mirochnick, M, Buschur, S, Jackson, C, Paul, M, McGregor, D, Yogev, R, Kalra, R, Florez, C, Bryan, P, Stone, M, Hull, AD, Caffery, M, Spector, SA, Wilson, J, Giner, J, Donnelly, MA, Cooper, ER, McLaud, DA, Tucker, LF, Hitti, J, Robson-Nuss, A, Melvin, AJ, Keller, MA, Bolaris, MA, Hayes, J, Kamer, F, Spencer, LS, Homans, J, Metz, T, Wallace, J, Katai, A, Aziz, M, McNichols, M, Schmidt, J, Wara, D, Maka, K, Cohan, D, Deveikis, A, Batra, J, Alvarez, JJ, Carter, M, Deville, J, Janzen, C, Gutierrez, J, Cavallo, M, Purswani, M, Knapp, KM, Sublette, N, Wride, T

Publikováno v: Tran, AH; Best, BM; Stek, A; Wang, J; Capparelli, EV; Burchett, SK; et al.(2016). Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women. Journal of Acquired Immune Deficiency Syndromes, 72(3), 289-296. doi: 10.1097/QAI.0000000000000968. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/8jd889qr

© Copyright 2016 Wolters Kluwer Health, Inc. All rights reserved. Background: Rilpivirine pharmacokinetics is defined by its absorption, distribution, metabolism, and excretion. Pregnancy can affect these factors by changes in cardiac output, protei

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::17677237049946780747cb4a4ee9c807
http://www.escholarship.org/uc/item/8jd889qr

Pharmacokinetics of tenofovir during pregnancy and postpartum

Autor: Best, BM, Burchett, S, Li, H, Stek, A, Hu, C, Wang, J, Hawkins, E, Byroads, M, Watts, DH, Smith, E, Fletcher, CV, Capparelli, EV, Mirochnick, M, Aweeka, F, Chotivanich, N, Cressey, TR, Frenkel, LM, Gupta, A, Jennings, A, Jourdain, G, Kreitchmann, R, Patel, R, Rungruengthanakit, K, Shapiro, D, Sukrakanchana, PO, Kovacs, A, Homans, J, Spencer, LS, Kramer, F, Buschur, S, Hammill, H, Paul, ME, McMullen-Jackson, C, Melvin, A, Venema-Weiss, C, Lane, J, Hitti, J, Knapp, K, Edwin Thorpe, ET, Utech, LJ, Sublette, N, Wara, D, Cohan, D, Tilton, N, Vachon, ME, Baig, MM, Purswani, MU, Gutierrez, J, Luzuriaga, K, Cormier, S, McManus, M, Hull, A, Caffery, M, Norris, K, Spector, SA, Keller, MA, Ballagh, S, Hayes, J, Gonzalez, Y, Barr, E, Kennedy, T, Katai, A, Wallace, J, McAuley, JB, Cejtin, H, McNichols, M, Schmidt, J, Watson, D, Ference, J, Hilyard, C, Crain, M, Simpson, TY, Tita, ATN, Febo, IL, Zorrilla, CD, Tamayo-Agrait, V, Santos, R

Publikováno v: HIV Medicine, vol 16, iss 8
Best, BM; Burchett, S; Li, H; Stek, A; Hu, C; Wang, J; et al.(2015). Pharmacokinetics of tenofovir during pregnancy and postpartum. HIV Medicine, 16(8), 502-511. doi: 10.1111/hiv.12252. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/5bd9f2bf

© 2015 British HIV Association. Tenofovir disoproxil fumarate (TDF) is increasingly used in the highly active antiretroviral therapy (HAART) regimens of pregnant women, but limited data exist on the pregnancy pharmacokinetics of chronically dosed TD

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4702f930080e649b460eb90fe6db8211
https://escholarship.org/uc/item/5bd9f2bf

Health indicators among low income women who report a history of sex work: the population based Northern California Young Women's Survey

Autor: Cohan, D, Kim, A, Ruiz, J, Morrow, S, Reardon, J, Lynch, M, Klausner, J, Molitor, F, Allen, B, Green, A, Ferrero, D, Bell, S, Page-Shafer, K, Delgado, V, McFarland, W, t for

Objectives: We examined differences in demographic characteristics, HIV related risk behaviour, prevalence of sexually transmitted infections (STI), and HIV and other health concerns among women with and without a history of sex work. Methods: A seco

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d964c58c2fa5f15671759aea5e5d60e
https://europepmc.org/articles/PMC1745033/